Tradestie Institutional Equity Comparison Engine
NNVC vs GNPX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NNVC Overall Edge
NNVC Captures Institutional Edge (3โ0 Pillars ยท 5โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to NanoViricides Inc. (NNVC) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, NNVC trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus GNPX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, NNVC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against GNPX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
NNVC N/M vs GNPX N/M Fwd P/E
Growth & Margin Winner
NNVC
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner
NNVC
1Y -19.1% vs -56.6% ยท 52W Pos 27% vs 11%
Options & Structure Winner
NNVC
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
NNVC
NYSE American
NanoViricides Inc.
Pharmaceutical Preparations
$1.14
-2.56% 1D
Market Cap
$29.9M
1M Return
-17.99%
1Y Return
-19.15%
Forward P/E
N/M
Unified AI Score
48.1 / 100
HOLD
Tech 60.0
Fund 54.0
Flow 60.0
Mom 60.0
GNPX
NASDAQ
Genprex, Inc. Common Stock
Pharmaceutical Preparations
$1.45
-13.17% 1D
Market Cap
$2.2M
1M Return
-26.77%
1Y Return
-56.59%
Forward P/E
N/M
Unified AI Score
42.2 / 100
HOLD
Tech 25.0
Fund 47.0
Flow 50.0
Mom 59.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
NNVC -19.15%
GNPX -56.59%
Spread: +37.44 pp (NNVC Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
NNVC TTM Op. Margin: 0.0%
GNPX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NNVC vs GNPX. Trailing 12-month operating profitability (NNVC 0.0% vs GNPX 0.0%) and valuation multiples (NNVC N/M vs GNPX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NNVC | GNPX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $29.9M | $2.2M | Larger Scale | NNVC |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -179.2% | -233.7% | Higher ROE | NNVC |
| 52-Week Range Position Momentum | 27% ($1โ$2) | 11% ($0โ$10) | Stronger Trend | NNVC |
| Beta / 30D Volatility Risk Regime | 1.95ฮฒ ยท 69% Vol | -4.68ฮฒ ยท 96% Vol | Lower Realized Risk | NNVC |
| Unified Institutional Score Composite Signal | 48.1 / 100 (HOLD) | 42.2 / 100 (HOLD) | Higher Composite | NNVC |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full NNVC vs GNPX Buy Guide
NNVC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
GNPX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither NNVC nor GNPX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.